Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

43

Revenue 2017

Perjeta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.

FDA panel backs Perjeta in early breast cancer

FDA panel backs Perjeta in early breast cancer If the FDA follows its committee's advice, Perjeta would become the cornerstone of the first regimen to get the go-ahead for neoadjuvant use in the US. ... Analysts have predicted that expansion of its use into the neoadjuvant setting could boost Perjeta

Pfizer faces NICE rejection for lung cancer drug

Pfizer faces NICE rejection for lung cancer drug Avastin (bevacizumab) and Perjeta (pertuzumab).

Roche’s breast cancer drug too expensive for NHS use

Roche’s breast cancer drug too expensive for NHS use Roche's ambitions for breast cancer drug Perjeta were hit today when draft guidance was published advising against use of the drug on the NHS in England and Wales. ... would mean that Perjeta was offered to the NHS at a discount to its standard price of

New cancer drugs help drive Roche in first half

New cancer drugs help drive Roche in first half Perjeta, Kadcyla and Zelboraf support company growth. Uptake of new cancer treatments helped Roche to a 5 per cent increase in sales in the first half of 2013, while profits topped ... The performance of Roche's newer cancer drugs was also encouraging,

Roche's blood cancer antibody wins priority review in US

Roche's blood cancer antibody wins priority review in US It is the second FDA priority review for a Roche product announced this week, following the news that Perjeta (pertuzumab) will face a similar regulatory pathway for use before surgery (neoadjuvant

[ Previous 5 results ] 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics